. 2015 Apr 27;29(3):855–861. doi: 10.1111/jvim.12600

Table 2.

Clinicopathologic variables for all groups at last visit

Variable	CKD‐NT (n = 133)	CKD‐DH (n = 27)	Healthy‐NT (n = 124)	Healthy‐DH (n = 9)
Follow‐up (days)	316 (225, 512)	379 (281, 771)	666 (495, 1065)	939 (685, 1217)
Age (years)	15 (13, 17)^a	15 (14, 18)^a	14 (12, 16)^b	15 (14, 15)^ab
Weight (kg)	3.6 (3.0, 4.5)^a	3.7 (3.2, 4.3)^ab	4.3 (3.4, 5.1)^b	4.7 (3.4, 5.7)^b
SBP (mmHg)	138.4 (120.5, 148)^a	181.6 (175.0, 188.8)^b	133.4 (121.1, 146.1)^a	181.2 (174.8, 190)^b
Heart rate (bpm)	186 (168, 210)	180 (160, 204)	184 (176, 204)	192 (186, 208)
PCV (%)	34 (30, 38)^a	36 (29, 39)^ab	37 (34, 40)^b	37 (36, 40)^ab
Albumin (g/dL)	3.1 (2.9, 3.3)	3.1 (2.9, 3.3)	3.1 (3.0, 3.4)	3.2 (3.1, 3.4)
Creatinine (mg/dL)	2.5 (2.1, 3.3)^a	2.7 (2.4, 3.0)^a	1.4 (1.3, 1.7)^b	1.6 (1.4, 1.9)^b
Urea (mmol/L)	16.9 [13.6, 22.0)^a	17.1 (15.2, 21.1)^a	10.5 (8.8, 12)^b	10.9 (9, 11.8)^b
Phosphate (mg/dL)	4.15 (3.55, 5.04)^a	4.28 (3.72, 5.16)^a	3.81 (3.50, 4.31)^b	4.06 (3.53, 4.56)^ab
Total calcium (mg/dL)	10.4 (10.0, 10.8)^a	10.6 (10.1, 11.0)^a	9.9 (9.5, 10.2)^b	9.9 (9.8, 10.2)^ab
Sodium (mEq/L)	154.3 (152.2, 156.4)^a	153.8 (151.7, 154.9)^ab	153.6 (152.0, 154.9)^b	152.7 (151.0, 153.6)^ab
Potassium (mEq/L)	4.20 (3.95, 4.50)^a	4.10 (3.95, 4.55)^ab	4.05 (3.80, 4.30)^b	4.20 (3.79, 4.40)^ab
Chloride (mEq/L)	119.1 (117.4, 120.8)	117.7 (115.8, 119.6)	118.9 (117.2, 120.8)	118.7 (117.3, 119.4)
Cholesterol (mg/dL)	200 (157, 247)^a	212 (177, 256)^ab	177 (147, 219)^b	201 (151, 236)^ab
USG	1.018 (1.016, 1.022)^a	1.018 (1.015, 1.019)^a	1.047 (1.032, 1.054)^b	1.034 (1.034, 1.038)^b

CKD‐DH, CKD‐developed‐hypertension; CKD‐NT, CKD‐remained normotensive; SBP, systolic blood pressure; PCV, packed cell volume; USG, urine specific gravity.

Parameters shown are at last included visit for the‐NT groups and first hypertensive visit for the‐DH groups. Superscript letters identify groups, which differed significantly.